How Bayer’s FDA Approval of AMBELVIST & Juwel Deal Boosts Growth Amid Rising DAX
Explore Bayer AG’s latest FDA‑approved AMBELVIST, new “Juwel” partnership, and market gains—discover how these moves boost its diagnostics and pharma portfolio.
4 minutes to read